Walleye Trading
RVNC

Walleye Trading’s Revance Therapeutics, Inc. RVNC Stock Holding History

Walleye Trading’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,800
Closed -$67.9K – 5057
2024
Q1 		$67.9K Sell
13,800
-12,500
-48% -$74K ﹤0.01% 3920
2023
Q4 		$231K Buy
26,300
+18,400
+233% +$151K ﹤0.01% 3680
2023
Q3 		$90.6K Sell
7,900
-10,300
-57% -$198K ﹤0.01% 4012
2023
Q2 		$461K Buy
18,200
+7,700
+73% +$240K ﹤0.01% 2808
2023
Q1 		$338K Sell
10,500
-12,400
-54% -$387K ﹤0.01% 3126
2022
Q4 		$423K Buy
22,900
+18,600
+433% +$425K ﹤0.01% 2946
2022
Q3 		$116K Sell
4,300
-4,700
-52% -$95.3K ﹤0.01% 3998
2022
Q2 		$124K Buy
9,000
+8,700
+2,900% +$134K ﹤0.01% 4028
2022
Q1 		$6K Sell
300
-8,100
-96% -$123K ﹤0.01% 5073
2021
Q4 		$137K Sell
8,400
-4,700
-36% -$78.4K ﹤0.01% 4199
2021
Q3 		$365K Buy
13,100
+7,000
+115% +$200K ﹤0.01% 3255
2021
Q2 		$181K Buy
+6,100
New +$176K ﹤0.01% 4006
2021
Q1 		– Sell
-1,600
Closed -$45K – 5409
2020
Q4 		$45K Sell
1,600
-6,400
-80% -$166K ﹤0.01% 4211
2020
Q3 		$201K Buy
+8,000
New +$210K ﹤0.01% 2991

Other funds holding RVNC

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Trading's RVNC Position: Q2 2024 in Review

Walleye Trading sold out of Revance Therapeutics, Inc. (RVNC) in Q2 2024, closing a stake of 16,078 shares — an estimated $79.1K sold.

Walleye Trading first reported a position in RVNC in Q2 2015 and held it in 15 quarters. The position peaked at $2.85M in Q3 2022. 173 funds tracked by Wall St. Rank hold RVNC as of Q2 2024.

  • Walleye Trading reported no remaining Revance Therapeutics, Inc. position as of Q2 2024 after selling out during the quarter.
  • Walleye Trading sold 16,078 Revance Therapeutics, Inc. shares in Q2 2024, an estimated $79.1K.
  • Walleye Trading first reported a position in Revance Therapeutics, Inc. in Q2 2015 and held it in 15 quarters.
  • Walleye Trading's Revance Therapeutics, Inc. position peaked at $2.85M in Q3 2022.
  • 173 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q2 2024.

Based on Walleye Trading's 13F filing for Q2 2024, filed 14 Aug 2024.